Company profile SWTX
After 39 days of this quarter the interest is at 155.0. Based on that we can calculate that during remaining 52 days it will total up to 362.0. SpringWorks Therapeutics expected interest is significantly higher compared to same quarter last year (+49.0%) but similar to previous quarter.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 148 | 166 12.2% QoQ | 258 55.4% QoQ | 109 -57.8% QoQ |
| 2020 | 137 -7.4% YoY 25.7% QoQ | 123 -25.9% YoY -10.2% QoQ | 98 -62.0% YoY -20.3% QoQ | 87 -20.2% YoY -11.2% QoQ |
| 2021 | 211 54.0% YoY 142.5% QoQ | 254 106.5% YoY 20.4% QoQ | 93 -5.1% YoY -63.4% QoQ | 194 123.0% YoY 108.6% QoQ |
| 2022 | 185 -12.3% YoY -4.6% QoQ | 196 -22.8% YoY 5.9% QoQ | 242 160.2% YoY 23.5% QoQ | 122 -37.1% YoY -49.6% QoQ |
| 2023 | 243 31.4% YoY 99.2% QoQ | 231 17.9% YoY -4.9% QoQ | 340 40.5% YoY 47.2% QoQ | 421 245.1% YoY 23.8% QoQ |
| 2024 | 155 -36.2% YoY -63.2% QoQ | - | - | - |
The average 5 years interest of SpringWorks Therapeutics was 15.38 per week. The last year interest of SpringWorks Therapeutics compared to the last 5 years has changed by 58.52%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 73.4%.
After 39 days of this quarter the interest is at 137.0. Based on that we can calculate that during remaining 52 days it will total up to 320.0. nirogacestat expected interest is significantly higher compared to previous quarter (+156.0%) and same quarter last year (+764.9%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 0 | 19 inf% QoQ | 22 15.8% QoQ | 6 -72.7% QoQ |
| 2020 | 55 inf% YoY 816.7% QoQ | 28 47.4% YoY -49.1% QoQ | 37 68.2% YoY 32.1% QoQ | 46 666.7% YoY 24.3% QoQ |
| 2021 | 27 -50.9% YoY -41.3% QoQ | 28 0.0% YoY 3.7% QoQ | 0 -100.0% YoY -100.0% QoQ | 21 -54.3% YoY inf% QoQ |
| 2022 | 82 203.7% YoY 290.5% QoQ | 75 167.9% YoY -8.5% QoQ | 88 inf% YoY 17.3% QoQ | 39 85.7% YoY -55.7% QoQ |
| 2023 | 37 -54.9% YoY -5.1% QoQ | 60 -20.0% YoY 62.2% QoQ | 99 12.5% YoY 65.0% QoQ | 125 220.5% YoY 26.3% QoQ |
| 2024 | 137 270.3% YoY 9.6% QoQ | - | - | - |
The average 5 years interest of nirogacestat was 3.95 per week. The last year interest of nirogacestat compared to the last 5 years has changed by 116.2%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 366.67%.
There is not enough data for desmoid tumors to provide analysis
There is not enough data for desmoid tumors to provide correlation calculation
There is not enough data for desmoid tumors to provide analysis
After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0. mirdametinib expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 38 | 0 -100.0% QoQ | 52 inf% QoQ | 125 140.4% QoQ |
| 2020 | 145 281.6% YoY 16.0% QoQ | 151 inf% YoY 4.1% QoQ | 54 3.8% YoY -64.2% QoQ | 58 -53.6% YoY 7.4% QoQ |
| 2021 | 161 11.0% YoY 177.6% QoQ | 138 -8.6% YoY -14.3% QoQ | 89 64.8% YoY -35.5% QoQ | 196 237.9% YoY 120.2% QoQ |
| 2022 | 24 -85.1% YoY -87.8% QoQ | 160 15.9% YoY 566.7% QoQ | 124 39.3% YoY -22.5% QoQ | 110 -43.9% YoY -11.3% QoQ |
| 2023 | 58 141.7% YoY -47.3% QoQ | 149 -6.9% YoY 156.9% QoQ | 263 112.1% YoY 76.5% QoQ | 130 18.2% YoY -50.6% QoQ |
| 2024 | 0 -100.0% YoY -100.0% QoQ | - | - | - |
The average 5 years interest of mirdametinib was 8.52 per week. The last year interest of mirdametinib compared to the last 5 years has changed by 30.52%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 141.74%.
After 39 days of this quarter the interest is at 263.0. Based on that we can calculate that during remaining 52 days it will total up to 614.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 340 | 507 49.1% QoQ | 462 -8.9% QoQ | 443 -4.1% QoQ |
| 2020 | 454 33.5% YoY 2.5% QoQ | 360 -29.0% YoY -20.7% QoQ | 388 -16.0% YoY 7.8% QoQ | 317 -28.4% YoY -18.3% QoQ |
| 2021 | 413 -9.0% YoY 30.3% QoQ | 466 29.4% YoY 12.8% QoQ | 533 37.4% YoY 14.4% QoQ | 400 26.2% YoY -25.0% QoQ |
| 2022 | 556 34.6% YoY 39.0% QoQ | 557 19.5% YoY 0.2% QoQ | 580 8.8% YoY 4.1% QoQ | 465 16.2% YoY -19.8% QoQ |
| 2023 | 566 1.8% YoY 21.7% QoQ | 571 2.5% YoY 0.9% QoQ | 537 -7.4% YoY -6.0% QoQ | 514 10.5% YoY -4.3% QoQ |
| 2024 | 263 -53.5% YoY -48.8% QoQ | - | - | - |
The average 5 years interest of neurofibromatosis type 1 was 37.13 per week. The last year interest of neurofibromatosis type 1 compared to the last 5 years has changed by 14.46%. The interest for neurofibromatosis type 1 is seasonal. The last year interest is comparable to 5 years ago. It has changed only by 13.7%.
There is not enough data for NF1-PN to provide analysis
There is not enough data for NF1-PN to provide correlation calculation
There is not enough data for NF1-PN to provide analysis
After 39 days of this quarter the interest is at 74.0. Based on that we can calculate that during remaining 52 days it will total up to 173.0. lifirafenib expected interest is significantly higher compared to previous quarter (+154.4%) but similar to same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 93 | 84 -9.7% QoQ | 100 19.0% QoQ | 94 -6.0% QoQ |
| 2020 | 94 1.1% YoY 0.0% QoQ | 80 -4.8% YoY -14.9% QoQ | 60 -40.0% YoY -25.0% QoQ | 155 64.9% YoY 158.3% QoQ |
| 2021 | 69 -26.6% YoY -55.5% QoQ | 55 -31.2% YoY -20.3% QoQ | 0 -100.0% YoY -100.0% QoQ | 72 -53.5% YoY inf% QoQ |
| 2022 | 43 -37.7% YoY -40.3% QoQ | 64 16.4% YoY 48.8% QoQ | 74 inf% YoY 15.6% QoQ | 69 -4.2% YoY -6.8% QoQ |
| 2023 | 143 232.6% YoY 107.2% QoQ | 110 71.9% YoY -23.1% QoQ | 52 -29.7% YoY -52.7% QoQ | 68 -1.4% YoY 30.8% QoQ |
| 2024 | 74 -48.3% YoY 8.8% QoQ | - | - | - |
The average 5 years interest of lifirafenib was 6.33 per week. The last year interest of lifirafenib compared to the last 5 years has changed by 19.75%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by -4.53%.
After 39 days of this quarter the interest is at 267.0. Based on that we can calculate that during remaining 52 days it will total up to 623.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 306 | 412 34.6% QoQ | 434 5.3% QoQ | 380 -12.4% QoQ |
| 2020 | 401 31.0% YoY 5.5% QoQ | 417 1.2% YoY 4.0% QoQ | 435 0.2% YoY 4.3% QoQ | 471 23.9% YoY 8.3% QoQ |
| 2021 | 435 8.5% YoY -7.6% QoQ | 384 -7.9% YoY -11.7% QoQ | 402 -7.6% YoY 4.7% QoQ | 440 -6.6% YoY 9.5% QoQ |
| 2022 | 643 47.8% YoY 46.1% QoQ | 619 61.2% YoY -3.7% QoQ | 517 28.6% YoY -16.5% QoQ | 494 12.3% YoY -4.4% QoQ |
| 2023 | 724 12.6% YoY 46.6% QoQ | 643 3.9% YoY -11.2% QoQ | 597 15.5% YoY -7.2% QoQ | 585 18.4% YoY -2.0% QoQ |
| 2024 | 267 -63.1% YoY -54.4% QoQ | - | - | - |
The average 5 years interest of solid tumors was 38.34 per week. The last year interest of solid tumors compared to the last 5 years has changed by 25.04%. The interest for solid tumors is trending. The last year interest is quite higher compared to 5 years ago. It has increased by 46.02%.
After 39 days of this quarter the interest is at 18.0. Based on that we can calculate that during remaining 52 days it will total up to 42.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 45 | 27 -40.0% QoQ | 129 377.8% QoQ | 42 -67.4% QoQ |
| 2020 | 69 53.3% YoY 64.3% QoQ | 140 418.5% YoY 102.9% QoQ | 21 -83.7% YoY -85.0% QoQ | 112 166.7% YoY 433.3% QoQ |
| 2021 | 93 34.8% YoY -17.0% QoQ | 99 -29.3% YoY 6.5% QoQ | 48 128.6% YoY -51.5% QoQ | 91 -18.8% YoY 89.6% QoQ |
| 2022 | 88 -5.4% YoY -3.3% QoQ | 41 -58.6% YoY -53.4% QoQ | 0 -100.0% YoY -100.0% QoQ | 115 26.4% YoY inf% QoQ |
| 2023 | 37 -58.0% YoY -67.8% QoQ | 64 56.1% YoY 73.0% QoQ | 138 inf% YoY 115.6% QoQ | 68 -40.9% YoY -50.7% QoQ |
| 2024 | 18 -51.4% YoY -73.5% QoQ | - | - | - |
The average 5 years interest of BGB-3245 was 5.69 per week. The last year interest of BGB-3245 compared to the last 5 years has changed by 9.84%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 21.36%.
After 39 days of this quarter the interest is at 122.0. Based on that we can calculate that during remaining 52 days it will total up to 285.0. BRAF mutations expected interest is significantly higher compared to previous quarter (+143.6%) and same quarter last year (+83.9%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 137 | 29 -78.8% QoQ | 71 144.8% QoQ | 103 45.1% QoQ |
| 2020 | 206 50.4% YoY 100.0% QoQ | 142 389.7% YoY -31.1% QoQ | 137 93.0% YoY -3.5% QoQ | 118 14.6% YoY -13.9% QoQ |
| 2021 | 198 -3.9% YoY 67.8% QoQ | 145 2.1% YoY -26.8% QoQ | 131 -4.4% YoY -9.7% QoQ | 89 -24.6% YoY -32.1% QoQ |
| 2022 | 152 -23.2% YoY 70.8% QoQ | 24 -83.4% YoY -84.2% QoQ | 153 16.8% YoY 537.5% QoQ | 299 236.0% YoY 95.4% QoQ |
| 2023 | 155 2.0% YoY -48.2% QoQ | 238 891.7% YoY 53.5% QoQ | 53 -65.4% YoY -77.7% QoQ | 117 -60.9% YoY 120.8% QoQ |
| 2024 | 122 -21.3% YoY 4.3% QoQ | - | - | - |
The average 5 years interest of BRAF mutations was 10.8 per week. The last year interest of BRAF mutations compared to the last 5 years has changed by 5.93%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 52.94%.
There is not enough data for TEA Domain inhibitors to provide analysis
There is not enough data for TEA Domain inhibitors to provide correlation calculation
There is not enough data for TEA Domain inhibitors to provide analysis
There is not enough data for Epidermal Growth Factor Receptor inhibitors to provide analysis
There is not enough data for Epidermal Growth Factor Receptor inhibitors to provide correlation calculation
There is not enough data for Epidermal Growth Factor Receptor inhibitors to provide analysis